Congressional Briefing
Advancing Regenerative Medicine and Cell Therapies for Patients in Need
Friday, June 18, 2021 – 1pm to 2pm ET
Opening Remarks
Congressman Ted Deutch
Remarks from Sterling Sharpe, Former NFL Player, Green Bay Packers
Promising Research Underway
Deverra Therapeutics, University of Washington
University of Miami, Miller School of Medicine
Sanford Health
Georgia Tech
Key Challenges
Deverra Therapeutics, University of Washington
University of Miami, Miller School of Medicine
Sanford Health
Georgia Tech
Policy Actions Needed
Deverra Therapeutics, University of Washington
University of Miami, Miller School of Medicine
Sanford Health
Georgia Tech
Key Take-aways
Deverra Therapeutics, University of Washington
University of Miami, Miller School of Medicine
Sanford Health
Georgia Tech
Closing Remarks
Janet Marchibroda
Alliance for Cell Therapy Now
Billy Davis and Kyle Richardson
NFL Alumni
Special Guest
Congressman Ted Deutch (D-FL)
Sterling Sharpe
Former NFL Player, Green Bay Packers; Five-Time Pro-Bowler
Panelists
Colleen Delaney, MD, M.S.c.
Founder, Chief Scientific Officer and EVP of R&D, Deverra Therapeutics and Professor, Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of Washington
Joshua M. Hare, MD, FACC, FAHA
Louis Lemberg Professor of Medicine, Founding Director, Interdisciplinary Stem Cell Institute, University of Miami, Miller School of Medicine
David A. Pearce, PhD
President of Innovation, Research, and World Clinic, Sanford Health; Senior Scientist, Sanford Children’s Health Research Center; Professor of Pediatrics, University of South Dakota Sanford School of Medicine
Krishnendu Roy, Ph.D.
Robert A. Milton Chair; Director, NSF Engineering Research Center for Cell Manufacturing Technologies; Director, Marcus Center for Cell-Therapy Characterization and Manufacturing; Technical Lead, National Cell Manufacturing Consortium; Director, Center for ImmunoEngineering, Georgia Institute of Technology
Co-Hosts
Janet Marchibroda
President
Alliance for Cell Therapy Now
Billy Davis
Co-Director, Health Care Initiatives, NFL Alumni
Kyle Richardson
Board Member and Co-Director, Health Care Initiatives, NFL Alumni
Panelists explored
The need for new treatments and cures among patients.
Promising results of early phase clinical studies for patients with serious and life-threatening conditions.
Policy actions needed to bring promising new therapies to patients in need.